In an age where neurodegenerative diseases like Alzheimer’s are becoming increas...
Since its launch, NASA’s Voyager 1 spacecraft has embarked on an extraordinary j...
In a remarkable study that sheds light on the evolutionary marvels of the Brassi...
In a groundbreaking study conducted by researchers at the FAMU-FSU College of En...
A groundbreaking initiative emerging from the University of California, San Dieg...
Recent discussions surrounding children’s engagement with technology have pivote...
The latest Phase 3 trial results for Immunovant’s batoclimab drug showed achieve...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced...
Sanofi will commence a Phase I/II trial with its vaccine candidate in the next f...
While Cassava is stopping investigations into simufilam in Alzheimer’s disease, ...
Character Biosciences has raised $93m in an oversubscribed Series B funding roun...
MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral ...
MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent co...
EU member states are set to launch the EU Health Data Space Regulation for harmo...
Ensuring the highest standards in pharmaceutical logistics is crucial for patien...
The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infe...
